Mapping Clinical Progression to Brain Atrophy in CLN2 Patients Under Cerliponase Alfa Treatment: A Prospective Neuroimaging Study
Petersen M, Westermann L, Hagenah L, Nickel M, Schwering C, Wibbeler E, Naegele F, Gloyer N, Flottmann F, Fiehler J, Thomalla G, Cheng B, Schulz A
J INHERIT METAB DIS. 2026;49(3):e70202.

Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfa
Schulz A, Schwering C, Wibbeler E, Westermann L, Hagenah L, Lezius S, Jha A, Hunt A, Slasor P, Reisewitz P, Nickel M
FRONT NEUROL. 2025;16:1516026.

Letzte Aktualisierung aus dem FIS: 12.06.2026 - 00:42 Uhr